Biblio
Export 1756 results:
Author Title [ Type] Year Filters: First Letter Of Last Name is L [Clear All Filters]
“Autonomic Nervous System Dysfunctions as a Basis for a Predictive Model of Risk of Neurological Disorders in Subjects with Prior History of Traumatic Brain Injury: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 305-315, 2017.
, “AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.”, J Alzheimers Dis, vol. 53, no. 2, pp. 583-620, 2016.
, “Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
, “Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1377-1383, 2018.
, “B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1453-1461, 2022.
, “BACE2: A Promising Neuroprotective Candidate for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S159-S171, 2023.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1459-1470, 2017.
, “BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function.”, J Alzheimers Dis, vol. 55, no. 2, pp. 645-657, 2017.
, “Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1325-40, 2016.
, “Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
, “Benefits of Occupational Therapy in Dementia Patients: Findings from a Real-World Observational Study.”, J Alzheimers Dis, vol. 56, no. 2, pp. 509-517, 2017.
, “Best Linear Unbiased Prediction of Individual Polygenic Susceptibility to Sporadic Vascular Dementia.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1115-9, 2016.
, “Beyond a Differential Diagnosis: Cognitive and Morphometric Decoding of Information Processing Speed in Senior Adults with DSM-5 Mild Neurocognitive Disorders.”, J Alzheimers Dis, vol. 58, no. 3, pp. 927-937, 2017.
, “Beyond a Differential Diagnosis: Cognitive and Morphometric Decoding of Information Processing Speed in Senior Adults with DSM-5 Mild Neurocognitive Disorders.”, J Alzheimers Dis, vol. 58, no. 3, pp. 927-937, 2017.
, “Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.”, J Alzheimers Dis, vol. 62, no. 2, pp. 821-831, 2018.
, “Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.”, J Alzheimers Dis, vol. 63, no. 2, pp. 577-590, 2018.
, “Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
, “Biofunctionalized Silica Nanoparticles: Standards in Amyloid-β Oligomer-Based Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 79-88, 2016.
, “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
, “Biological Factors Contributing to the Response to Cognitive Training in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 1, pp. 333-345, 2018.
, “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
, “Biomarker Exposure-Response Analysis in Mild-To-Moderate Alzheimer's Disease Trials of Bapineuzumab.”, J Alzheimers Dis, vol. 53, no. 2, pp. 535-46, 2016.
, “Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.”, J Alzheimers Dis, vol. 55, no. 3, pp. 973-979, 2017.
,